Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 820-824

  Kao, Chia Hung ^a   Hsieh, Jih Fang ^b   Tsai, Shih Chuan ^c   Ho, Yung Jen ^d   Lee, Jong Kang ^e  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHI MEI FOUNDATION HOSPITAL   (Taiwan)

^c Show Chwan Hospital   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PACLITAXEL;

ACCURACY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; P-GLYCOPROTEIN; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0034019465     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Smit, E. F., and Postmus, P. E. Chemotherapy of non-small cell lung cancer. In: D. N. Carney (ed.), Lung Cancer, pp. 156-172. London: The Bath Press, Avon, 1995.
2. Paul, D. M., and Johnson, D. H. Chemotherapy for non-small-cell lung cancer. In: B. E. Johnson and D. H. Johnson, (eds.), Lung Cancer, pp. 247-261. New York: Wiley-Liss, 1995.
3. Alberola, V., Rosell, R., Gonzalez-Larriba, J. L., Molina, F., Ayala, F., Garcia-Conde, J., Benito, D., and Perez, J. M. Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer. Ann. Oncol., 6 (Suppl. 3): S49-S52, 1995.
4. Donebower, R. C., and Rowinsky, E. K. Paciltaxel. Principle & Practice of Oncology, 10: 1-16, 1994.
5. Arbuck, S. G., Dorr, A., and Friedman, M. A. Paclitaxel (Taxol) in breast cancer. Breast Cancer, 8: 121-140, 1994.
6. Francis, P. A., Kris, M. G., Rigas, J. R., Grant, S. C., and Miller, V. A. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer. Lung Cancer, 12 (Suppl. 1): S163-S172, 1995.
7. van-Ark-Otte, J., Samelis, G., Rubio, G., Lopez-Saez, J. B., Pinedo, H. M., and Giaccone, G. Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes. Oncol. Rep., 5: 249-255, 1998.
8. Horwitz, S. B., Cohen, D., Rao, S., Ringel, I., Shen, H. J., and Yang, C. P. Taxol: mechanism of action and resistance. Natl. Cancer Inst. Monogr., 15: 55-61, 1993.
9. Horwitz, S. B., Lothstein, L., Manfredi, J. J., Mellado, W., Parness, J., Roy, S. N., Schiff, P. B., Sorbara, L., and Zeheb, R. Taxol: mechanisms of action and resistance. Ann. NY Acad. Sci., 466: 733-744, 1986.
10. Hendrikse, N. H., Franssen, E. J., van der Graaf, W. T., Vaalburg, W., and de Vries, E. G. Visualization of multidrug resistance in vivo. Eur. J. Nucl. Med., 26: 283-293, 1999.
11. Bae, K. T., and Piwnica Worms, D. Pharmacokinetic modeling of multidrug resistance P-glycoprotein transport of γ-emitting substrates. Q. J. Nucl. Med., 41: 101-110, 1997.
12. Kao, C. H., Wang, S. J., Lin, W. Y., Hsu, C. Y., Liao, S. Q., and Yen, S. H. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technelium-99m methoxy-isobutylisonitrile. Eur. J. Nucl. Med., 20: 249-254, 1993.
13. Kostakoglu, L., Kiratli, P., Ruacan, S., Hayran, M., Emri, S., Ergun, E. L., and Bekdik, C. F. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J. Nucl. Med., 39: 228-234, 1998.
14. Kostakoglu, L., Elahi, N., Kiratli, P., Ruacan, S., Sayek, I., Baltali, E., Sungur, A., Hayran, M., and Bekdik, C. F. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. J. Nucl. Med., 38: 1003-1008, 1997.
15. Kao, C. H., ChangLai, S. P., Chieng, P. U., and Yen, T. C. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma. Relationship to patient prognosis and chemotherapy response - a preliminary report. Cancer (Phila.). 83: 64-68, 1998.
16. Bom, H. S., Kim, Y. C., Song, H. C., Min, J. J., Kim, J. Y., and Park, K. O. Technetium-99m-MIBI uptake in small cell lung cancer. J. Nucl. Med., 39: 91-94, 1998.
17. Yamamoto, Y., Nishiyama, Y., Satoh, K., Takashima, H., Ohkawa, M., Fujita, J., Kishi, T., Matsuno, S., and Tanabe, M. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer. J. Nucl. Med., 39: 1626-1629, 1998.
18. Ceriani, L., Giovanella, L., Bandera, M., Beghe, B., Ortelli, M., and Roncari, G. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy. Nucl. Med. Commun., 18: 1087-1097, 1997.
19. Koukourakis, M. I., Koukouraki, S., Giatromanolaki, A., Skarlatos, J., Georgoulias, V., and Karkavitsas, N. Non-small cell lung cancer functional imaging: increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment. Clin. Cancer Res., 3: 749-754, 1997.
20. Hsu, J. W., Hsu, J. Y., and Chiang, C. D. Preliminary result of phase II study of paclitaxel and cisplatin chemotherapy for advanced non-small-cell lung cancer in Chinese patients. Am. J. Clin. Oncol., 21: 487-490, 1998.
21. Oken, M. M., Creech, R. H., and Tormey, D. C. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol., 5: 649-655, 1982.
22. Piwnica-Worms, D., Chiu, M. L., Budding, M., Kronauge, J. F., Kramer, R. A., and Croop, J. M. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res., 53: 977-984, 1993.